Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method and device for identifying adverse drug reaction

A technology of adverse reactions and identification methods, applied in drug reference, patient-specific data, structured data retrieval, etc., can solve problems such as missed reports, reduce accurate judgment of adverse reactions of drugs, and cannot clarify the number of "denominators", achieving good results External authenticity, short time-consuming, time-consuming and economical effects

Pending Publication Date: 2022-04-08
刘玉强
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, in the reporting of adverse drug reactions, passive spontaneous reports are mainly used as risk signals, but this kind of spontaneous reporting also has certain problems. On the one hand, the "denominator" number of exposed groups cannot be clearly determined, and the incidence of certain adverse reactions cannot be accurately calculated. ;The number of individual case reports is largely uncontrollable, sometimes the underreporting phenomenon is serious, and sometimes a large number of adverse reactions may be reported intensively due to the influence of the media, resulting in the inability to correctly evaluate the level of adverse reactions; and these The existence of the problem further reduces the accurate determination of the adverse reaction of the drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method and device for identifying adverse drug reaction
  • Method and device for identifying adverse drug reaction
  • Method and device for identifying adverse drug reaction

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0056]In order to make the purpose, technical solutions and advantages of this application clearer, the following in conjunction with the attached Figure 1-4 And embodiment, this application is described in further detail. It should be understood that the specific embodiments described here are only used to explain the present application, not to limit the present application.

[0057] Such as figure 1 As shown, the prescription symmetry analysis is based on the order and frequency distribution of drug use to determine whether there is a relationship between the drug and the adverse reaction event; the prescription symmetry analysis can use the label drug B to indicate the index drug A, and find that a certain drug A causes the adverse reaction events of the label drug B. reaction. This application further expands the prescription symmetry analysis. Through the interaction between the index drug A and the index drug C through the label drug B, it is found that the drug A an...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an adverse drug reaction identification method and device. The method comprises the following steps: acquiring medical record data of a patient using index drugs and label drugs in an investigation period from an electronic medical record system; using a pre-constructed general data model to extract standardized medical record data of the patient from the obtained medical record data to obtain a standardized data set; respectively confirming whether the first medicine and the second medicine in the index medicines can cause the adverse reaction treated by the label medicine or not; when all the index drugs cannot cause adverse reactions treated by the tag drugs, performing prescription sequence symmetric analysis on the index drugs and the tag drugs by using the obtained standardized data set, and outputting an analysis result; and according to an analysis result, determining whether the adverse reaction treated by the label medicine can be caused after the interaction of the index medicines. According to the method, the identification accuracy of the adverse reaction between the drugs is high, the speed is high, and therefore the level of the adverse reaction can be correctly evaluated.

Description

technical field [0001] The present application relates to the field of drug safety, in particular to a method and device for identifying adverse drug reactions. Background technique [0002] At present, the national drug administration department releases information on adverse drug reactions to the public, which is conducive to the general public's learning and mastering of drug knowledge and ensuring the lives, health and safety of the people. Therefore, monitoring adverse reactions of post-marketing drugs is very important for evaluating the safety and re-evaluation of real-world post-marketing drugs. At present, in the reporting of adverse drug reactions, passive spontaneous reports are mainly used as risk signals, but this kind of spontaneous reporting also has certain problems. On the one hand, the "denominator" number of exposed groups cannot be clearly determined, and the incidence of certain adverse reactions cannot be accurately calculated. ;The number of individu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G16H70/40G16H10/60G06F16/25
Inventor 刘玉强侯春霞王瑜王洁韩国霖张伟
Owner 刘玉强
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products